Cardinal Health has entered into an agreement to manufacture and distribute Eli Lilly and Company's new diagnostic imaging agent, Amyvid, at seven sites throughout the US. Amyvid, a radioactive diagnostic agent, tagged with a ...
The US Court of Appeals for the Federal Circuit has confirmed a prior ruling by the US District Court for the District of Delaware that the Eli Lilly and Company's compound patent for Alimta (pemetrexed) is valid. The compound patent ...
Mylan Pharmaceuticals has won final FDA approval for its abbreviated new drug application for Olanzapine tablets USP, 2.5mg, 5mg, 7.5mg, 10mg, 15mg, and 20mg. The company begins the shipment of the product, which is the generic equivalent ...
Tags: Generic Zyprexa Tablets, Mylan Pharmaceuticals, new drug
Eli Lilly and Company and Avid Radiopharmaceuticals have gained positive CHMP opinion for Amyvid (Florbetapir F 18 injection) for the use as a diagnostic tool for positron emission tomography (PET) imaging of beta-amyloid plaque density in ...
Tags: Amyvid, Positive CHMP Opinion, Cognitive Impairment Diagnosis
Eli Lilly and Company Alimta(pemetrexed for injection)has received FDA approval for new use in the continuation maintenance setting for advanced or metastatic nonsquamous non-small cell lung cancer(NS NSCLC). The approval was based on ...
Ten biopharmaceutical companies, Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi have established a non-profit organization ...
Tags: biopharmaceutical companies, non-profit organization, new medicines
The US Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) of Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company for Tradjenta (linagliptin) tablets for use as add-on therapy to insulin. ...
Tags: FDA, sNDA, pharmaceutical product, clinical development
Boehringer Ingelheim and Eli Lilly and Company have received European Commission marketing authorization for Jentadueto (linagliptin/metformin hydrochloride) tablets. Jentadueto is a new, single-tablet treatment option, taken twice daily, ...
Tags: marketing authorization, Jentadueto tablets, glycemic control
Elanco Food Solutions has launched CellVex–a new anti-microbial food safety product designed to lower E.coli and Salmonella pathogens in beef processing plants. CellVex is a liquid bromine product that combines with bleach to form ...
Tags: beef processing plants, anti-microbial food safety product, E.coli
Eli Lilly and Company has met the United States Food and Drug Administration (FDA) requirements for pediatric exclusivity for Cymbalta (duloxetine HCl), which is available in 20-mg, 30-mg, and 60-mg capsules. As part of the approval, ...
Eli Lilly and Company has officially opened the Lilly China Research and Development Center (LCRDC), a diabetes-focused research and development center in Shanghai, China. The focus of LCRDC is on the discovery of new diabetes medicines ...
Tags: Eli Lilly and Company, China Research and Development Center, diabetes